Garrett Motion Inc., together with its subsidiaries, designs, manufactures, and sells turbocharging, air and fluid compression, and high-speed electric motor technologies for original equipment manufacturers and distributors in the United States, Europe, Asia, and internationally. The company offers cutting-edge technology for the mobility and industrial space, including light vehicles, commercial vehicles, and industrial applications. It also provides mechanical and electrical products for turbocharging and boosting internal combustion engines, as well as compressing air for fuel cell compressors, and compressing refrigerant for electric cooling compressors. It offers its products in the aftermarket through distributors. Garrett Motion Inc. was incorporated in 2018 and is based in Rolle, Switzerland.

Garrett Motion Inc

The latest update is out from Garrett Motion ( ($GTX) ). On July 21, 2026, Garrett Motion’s Board of Directors appointed veteran powertrain executi...

Garrett Motion strengthens board with new independent director

TG Therapeutics ($TGTX) announced an update on their ongoing clinical study. The new TG Therapeutics study looks at how well maintenance use of BRI...

TG Therapeutics Targets Myasthenia Gravis Growth With New BRIUMVI Trial

Analysts have been eager to weigh in on the Healthcare sector with new ratings on TG Therapeutics (TGTX), Protagonist Therapeutics (PTGX) and PROCE...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: TG Therapeutics (TGTX), Protagonist Therapeutics (PTGX) and PROCEPT BioRobotics (PRCT)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Biogen (BIIB) and TG Therapeutics (TGTX). Biogen (...

Analysts Conflicted on These Healthcare Names: Biogen (BIIB) and TG Therapeutics (TGTX)

In a report released today, Rajat Gupta CFA from J.P. Morgan maintained a Hold rating on Gentex, with a price target of $28.00. According to TipRan...

Gentex (GNTX) Gets a Hold from J.P. Morgan

J.P. Morgan analyst Rajat Gupta CFA maintained a Buy rating on Garrett Motion today and set a price target of $33.00. Gupta CFA covers the Consumer...

J.P. Morgan Reaffirms Their Buy Rating on Garrett Motion (GTX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Meiragtx Holdings (MGTX) and Sensus Healthcare (SRTS...

Analysts Offer Insights on Healthcare Companies: Meiragtx Holdings (MGTX) and Sensus Healthcare (SRTS)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on COMPASS Pathways (CMPS), Meiragtx Holdings (MGTX) ...

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS), Meiragtx Holdings (MGTX) and Resmed (RMD)

Meiragtx Holdings ( ($MGTX) ) has issued an announcement. On June 30, 2026, MeiraGTx entered into a Royalty Note Purchase Agreement with Oberland C...

MeiraGTx Secures Major Royalty Financing and Restructures Debt

Bank of America Securities analyst Alec Stranahan reiterated a Sell rating on TG Therapeutics today and set a price target of $20.00. According to ...

Bank of America Securities Keeps Their Sell Rating on TG Therapeutics (TGTX)

There’s a lot to be optimistic about in the Consumer Cyclical sector as 2 analysts just weighed in on Red Rock Resorts (RRR) and Garrett Motion (GT...

Analysts Offer Insights on Consumer Cyclical Companies: Red Rock Resorts (RRR) and Garrett Motion (GTX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pacira Pharmaceuticals (PCRX), Akebia Therapeutics (...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	GTX	$28.78	-3.78%	3.54M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	GTX	$28.78	-3.8%	3.54M
3
4
5
6

GTX

GTX

Get Garrett Motion Inc Data in Excel

Get Garrett Motion Inc Data in Excel